71 related articles for article (PubMed ID: 7620163)
1. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
[TBL] [Abstract][Full Text] [Related]
2. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
Quiroga MP; Balakrishnan K; Kurtova AV; Sivina M; Keating MJ; Wierda WG; Gandhi V; Burger JA
Blood; 2009 Jul; 114(5):1029-37. PubMed ID: 19491390
[TBL] [Abstract][Full Text] [Related]
3. Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation.
Lankar D; Briken V; Adler K; Weiser P; Cassard S; Blank U; Viguier M; Bonnerot C
J Exp Med; 1998 Sep; 188(5):819-31. PubMed ID: 9730884
[TBL] [Abstract][Full Text] [Related]
4. Role of Syk in B-cell development and antigen-receptor signaling.
Cornall RJ; Cheng AM; Pawson T; Goodnow CC
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1713-8. PubMed ID: 10677523
[TBL] [Abstract][Full Text] [Related]
5. The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters.
Lösing M; Goldbeck I; Manno B; Oellerich T; Schnyder T; Bohnenberger H; Stork B; Urlaub H; Batista FD; Wienands J; Engelke M
J Biol Chem; 2013 Jan; 288(4):2303-13. PubMed ID: 23223229
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?
García-Muñoz R; Llorente L
Immunology; 2014 Aug; 142(4):536-50. PubMed ID: 24645778
[TBL] [Abstract][Full Text] [Related]
7. Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells.
Hayakawa K; Formica AM; Colombo MJ; Shinton SA; Brill-Dashoff J; Morse Iii HC; Li YS; Hardy RR
Leukemia; 2016 Jul; 30(7):1510-9. PubMed ID: 27055869
[TBL] [Abstract][Full Text] [Related]
8. Formation of BCR oligomers provides a mechanism for B cell affinity discrimination.
Tsourkas PK; Somkanya C D; Yu-Yang P; Liu W; Pierce SK; Raychaudhuri S
J Theor Biol; 2012 Aug; 307():174-82. PubMed ID: 22613800
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in lymphocyte activation: linking kinases to downstream signaling events.
Clements JL; Koretzky GA
J Clin Invest; 1999 Apr; 103(7):925-9. PubMed ID: 10194464
[No Abstract] [Full Text] [Related]
10. B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Schmid VK; Hobeika E
Front Oncol; 2024; 14():1339620. PubMed ID: 38469232
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.
Cui X; Zhang L; Magli AR; Catera R; Yan XJ; Griffin DO; Rothstein TL; Barrientos J; Kolitz JE; Allen SL; Rai KR; Chiorazzi N; Chu CC
Leukemia; 2016 Jan; 30(1):74-85. PubMed ID: 26220042
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk after ABO-incompatible living-donor kidney transplantation.
Hall EC; Engels EA; Montgomery RA; Segev DL
Transplantation; 2013 Sep; 96(5):476-9. PubMed ID: 23799426
[TBL] [Abstract][Full Text] [Related]
13. Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL.
Efremov DG; Wiestner A; Laurenti L
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012067. PubMed ID: 23170196
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.
Negro R; Gobessi S; Longo PG; He Y; Zhang ZY; Laurenti L; Efremov DG
Blood; 2012 Jun; 119(26):6278-87. PubMed ID: 22569400
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular mechanisms of CLL: novel therapeutic approaches.
Pleyer L; Egle A; Hartmann TN; Greil R
Nat Rev Clin Oncol; 2009 Jul; 6(7):405-18. PubMed ID: 19488076
[TBL] [Abstract][Full Text] [Related]
16. Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.
Foster AE; Brenner MK; Dotti G
Best Pract Res Clin Haematol; 2008 Sep; 21(3):375-89. PubMed ID: 18790444
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
Gurrieri C; McGuire P; Zan H; Yan XJ; Cerutti A; Albesiano E; Allen SL; Vinciguerra V; Rai KR; Ferrarini M; Casali P; Chiorazzi N
J Exp Med; 2002 Sep; 196(5):629-39. PubMed ID: 12208878
[TBL] [Abstract][Full Text] [Related]
18. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
Kawauchi K; Ogasawara T; Yasuyama M
Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1.
Lee BS; Alvarez X; Ishido S; Lackner AA; Jung JU
J Exp Med; 2000 Jul; 192(1):11-21. PubMed ID: 10880522
[TBL] [Abstract][Full Text] [Related]
20. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
